• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫苗接种后的死亡率及死亡特征

Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination.

作者信息

Lv Gang, Yuan Jing, Xiong Xiaomo, Li Minghui

机构信息

Department of General Surgery, Chinese PLA General Hospital, Beijing, China.

Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China.

出版信息

Front Med (Lausanne). 2021 May 14;8:670370. doi: 10.3389/fmed.2021.670370. eCollection 2021.

DOI:10.3389/fmed.2021.670370
PMID:34055843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8160119/
Abstract

The emergency use authorization for coronavirus disease 2019 (COVID-19) vaccines brought both hopes and concerns to the Americans and others. We aimed to estimate the mortality rate of COVID-19 vaccination and presented characteristics of deaths following COVID-19 vaccination. Data on deaths following COVID-19 vaccination were obtained from the Vaccine Adverse Event Reporting System (VAERS) from December 11, 2020 through January 8, 2021. The Centers for Disease Control and Prevention (CDC) COVID Data Tracker was used to identify the total number of people receiving COVID-19 vaccines during the same period to estimate the mortality rate. Stratified analysis was conducted by the location of vaccination. As of January 8, 2021, 55 deaths were reported, and the mortality rate of COVID-19 vaccination was 8.2 per million population. A total of 37 deaths were reported among long-term care facility residents, and the mortality rate was 53.4 per million population. Top reported comorbidities associated with deaths included hypertension, dementia, chronic obstructive pulmonary disease (COPD), diabetes, and heart failure. In addition, dementia was more likely to be associated with deaths vaccinated at long-term care facilities than at other locations. The benefits of COVID-19 vaccines outweigh the potential risks in older frail populations, and our findings do not support actions to exclude older adults from being vaccinated. However, continued monitoring of COVID-19 vaccination is still warranted.

摘要

2019冠状病毒病(COVID-19)疫苗的紧急使用授权给美国人和其他人带来了希望和担忧。我们旨在估计COVID-19疫苗接种的死亡率,并呈现COVID-19疫苗接种后死亡的特征。2020年12月11日至2021年1月8日期间,COVID-19疫苗接种后死亡的数据来自疫苗不良事件报告系统(VAERS)。疾病控制和预防中心(CDC)的COVID数据追踪器用于确定同一时期接受COVID-19疫苗接种的总人数,以估计死亡率。按接种地点进行分层分析。截至2021年1月8日,报告了55例死亡,COVID-19疫苗接种的死亡率为每百万人口8.2例。长期护理机构居民中报告了37例死亡,死亡率为每百万人口53.4例。报告的与死亡相关的最常见合并症包括高血压、痴呆、慢性阻塞性肺疾病(COPD)、糖尿病和心力衰竭。此外,与其他地点相比,痴呆在长期护理机构接种疫苗后死亡中更可能相关。在体弱的老年人群中,COVID-19疫苗的益处大于潜在风险,我们的研究结果不支持将老年人排除在接种疫苗之外的行动。然而,仍有必要继续监测COVID-19疫苗接种情况。

相似文献

1
Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination.新冠疫苗接种后的死亡率及死亡特征
Front Med (Lausanne). 2021 May 14;8:670370. doi: 10.3389/fmed.2021.670370. eCollection 2021.
2
Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis.新型冠状病毒肺炎疫苗接种后自身免疫性肝炎的真实世界证据:一项基于人群的药物警戒分析。
Front Pharmacol. 2023 Apr 13;14:1100617. doi: 10.3389/fphar.2023.1100617. eCollection 2023.
3
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日:在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应(包括过敏反应)。
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.
4
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
5
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.美国 2020 年 12 月 21 日-2021 年 1 月 10 日期间,在接种 Moderna COVID-19 疫苗第一针后出现过敏反应(包括过敏反应)。
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1.
6
Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program - United States, December 2020-January 2021.参与长期护理计划药房合作伙伴关系的熟练护理设施居民和工作人员的 COVID-19 早期第一剂疫苗接种率-美国,2020 年 12 月至 2021 年 1 月。
MMWR Morb Mortal Wkly Rep. 2021 Feb 5;70(5):178-182. doi: 10.15585/mmwr.mm7005e2.
7
Allergic reactions to Japanese encephalitis vaccine.对日本脑炎疫苗的过敏反应。
Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. doi: 10.1016/s0889-8561(03)00102-4.
8
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
9
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.2009-2015 年疫苗不良事件报告系统(VAERS)中四价人乳头瘤病毒疫苗上市后安全性监测。
Vaccine. 2018 Mar 20;36(13):1781-1788. doi: 10.1016/j.vaccine.2018.02.034. Epub 2018 Feb 21.
10
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.1991年至1998年脊髓灰质炎疫苗不良事件监测:灭活脊髓灰质炎疫苗随后接种口服脊髓灰质炎疫苗的序贯接种方案的影响
Pediatrics. 2001 May;107(5):E83. doi: 10.1542/peds.107.5.e83.

引用本文的文献

1
Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.保护还是预防?一个应对新冠疫苗优先排序困境的可行框架。
PLoS One. 2025 Jan 22;20(1):e0316294. doi: 10.1371/journal.pone.0316294. eCollection 2025.
2
COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19.新型冠状病毒肺炎相关心血管疾病——风险、预防与管理:因新型冠状病毒肺炎而面临风险的心脏
Curr Issues Mol Biol. 2024 Feb 29;46(3):1904-1920. doi: 10.3390/cimb46030124.
3
Lay beliefs of COVID-19 vaccine refusal among intercity commercial drivers in the Volta region of Ghana: recommendations for improved vaccine uptake.加纳沃尔特地区城际商业司机中拒绝接种新冠疫苗的民众观念:提高疫苗接种率的建议
Trop Dis Travel Med Vaccines. 2024 Mar 1;10(1):5. doi: 10.1186/s40794-023-00214-9.
4
Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: A retrospective cohort study.解读与新型冠状病毒2疫苗接种后严重不良事件相关的死亡:一项回顾性队列研究。
Vaccine X. 2024 Jan 20;16:100446. doi: 10.1016/j.jvacx.2024.100446. eCollection 2024 Jan.
5
Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data.解析 COVID-19 疫苗接种后不良事件和关联:深入挖掘疫苗不良事件报告系统数据。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):53-59. doi: 10.1080/14760584.2023.2292203. Epub 2023 Dec 14.
6
Awareness of and attitude toward COVID-19 vaccination among individuals with COPD and the strategies to overcome vaccine hesitation: A mini review.慢性阻塞性肺疾病患者对 COVID-19 疫苗的认知和态度,以及克服疫苗犹豫的策略:小型综述。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2286686. doi: 10.1080/21645515.2023.2286686. Epub 2023 Dec 7.
7
Risk of all-cause and cardiac-related mortality after vaccination against COVID-19: A meta-analysis of self-controlled case series studies.接种 COVID-19 疫苗后全因和心脏相关死亡率的风险:一项自我对照病例系列研究的荟萃分析。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2230828. doi: 10.1080/21645515.2023.2230828.
8
N-acetylcysteine as adjuvant therapy for hospitalized Covid-19 patients: A single-center prospective cohort study.N-乙酰半胱氨酸作为住院新冠肺炎患者的辅助治疗:一项单中心前瞻性队列研究。
Caspian J Intern Med. 2023 Summer;14(3):543-552. doi: 10.22088/cjim.14.3.553.
9
[Evaluation of the Dunning Kruger effect in relation to vaccination: a study of messages on the social network LinkedIn.].[关于疫苗接种的邓宁-克鲁格效应评估:对社交网络领英上信息的研究。]
Rev Esp Salud Publica. 2023 Jun 15;97:e202306051.
10
Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis.新型冠状病毒肺炎疫苗接种后自身免疫性肝炎的真实世界证据:一项基于人群的药物警戒分析。
Front Pharmacol. 2023 Apr 13;14:1100617. doi: 10.3389/fphar.2023.1100617. eCollection 2023.

本文引用的文献

1
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.接种辉瑞-生物科技公司新冠疫苗第一剂后包括过敏反应在内的过敏反应。
JAMA. 2021 Feb 23;325(8):780-781. doi: 10.1001/jama.2021.0600.
2
Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination.新冠疫情:挪威对体弱老年患者接种疫苗后出现的23例死亡病例展开调查。
BMJ. 2021 Jan 15;372:n149. doi: 10.1136/bmj.n149.
3
Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19.与 COVID-19 养老院居民全因 30 天死亡率相关的风险因素。
JAMA Intern Med. 2021 Apr 1;181(4):439-448. doi: 10.1001/jamainternmed.2020.7968.
4
Age and frailty in COVID-19 vaccine development.新冠疫苗研发中的年龄与虚弱问题
Lancet. 2021 Dec 19;396(10267):1942-1944. doi: 10.1016/S0140-6736(20)32481-8. Epub 2020 Nov 19.
5
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).疫苗不良事件报告系统(VAERS)中的安全性监测。
Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22.